Ansell (ASX:ANN) Delivers Revenue and Earnings Lift; Sets FY26 Outlook

Sonal Goyal

25 August 2025 02:40 PM AEST

Ansell (ASX:ANN) Delivers Revenue and Earnings Lift; Sets FY26 Outlook

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Sales reached US$2,003.3 million in FY25, up 23.7% on a reported basis and 7.7% on an organic constant currency basis.

EBIT increased to US$282.1 million, up 10.4% organically, with EBIT margin expanding to 14.1%.

FY26 Adjusted EPS guidance set at US133¢ to US145¢, supported by cost synergies, efficiency gains, and tariff-related pricing adjustments.

Ansell Limited (ASX:ANN), a global provider of personal protection and safety solutions, has released its financial results for the year ended 30 June 2025 (FY25), reporting revenue growth across both its Industrial and Healthcare segments.

FY25 Results

The company reported sales of US$2,003.3 million, an increase of 23.7% on a reported basis and 7.7% on an organic constant currency basis. Growth in the Industrial segment was 5.6%, driven by new product launches in both Mechanical and Chemical categories. The Healthcare segment delivered 9.4% growth, supported by recovery from prior year destocking and double-digit gains in the acquired Kimtech™ cleanroom portfolio.

Earnings before interest and tax (EBIT) reached US$282.1 million, up 44.3% on a reported basis and 10.4% on an organic constant currency basis. Improved manufacturing utilisation and efficiency savings under the Accelerated Productivity Investment Program (APIP) contributed to this growth, while freight and raw material cost pressures eased in the second half of the year. EBIT margin increased to 14.1%, aided by contributions from the integrated KBU business.

Adjusted earnings per share (EPS) rose 19.5% to US126.1¢, while statutory EPS was US69.9¢, reflecting a 17.7% increase. Operating cash flow was US$105.4 million, impacted by higher inventory investment ahead of US tariff increases. Net debt to EBITDA declined to 1.6x, highlighting balance sheet resilience.

The board declared a final dividend of US28.0¢, taking the full-year dividend to US50.2¢, an increase of 30.7% year-on-year. The dividend payout ratio was maintained at 40%, consistent with company policy.

Outlook for FY26

Looking ahead, Ansell expects Adjusted EPS in the range of US133¢ to US145¢ for FY26. While healthcare demand is expected to remain steady, the company anticipates softer conditions in some industrial segments. Tariffs in the United States are expected to be fully offset by price adjustments, with increases implemented in late FY25 and further increases scheduled in the first half of FY26.

Additional EBIT contributions are expected from cost synergies and efficiency programs, including ~US$7 million in incremental KBU synergies and ~US$3 million in further APIP savings, bringing cumulative APIP benefits to approximately US$50 million.

Capital expenditure for FY26 is forecast between US$60 million and US$70 million, with one-off costs of around US$15 million expected, largely related to enterprise resource planning (ERP) system upgrades. Net interest expense is projected at ~US$45 million, while the tax rate is forecast in the range of 23.5% to 24.5%.

ANN shares were trading 8.34% higher at AUD 33.91 per share at the time of writing on 25 August 2025.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.